Okay, let's tackle this question about G protein-coupled receptors. First, I need to recall what GPCRs are. They're a large family of membrane receptors that transmit signals from outside the cell to the inside. When a ligand binds to a GPCR, it activates a G protein, which then triggers a cascade of intracellular events.

The question is asking which option correctly identifies a characteristic or function of GPCRs. Since the options aren't provided, I have to think about common distractors. Let's consider typical choices: maybe about their structure, signaling pathways, or examples.

The correct answer should relate to their mechanism. For example, GPCRs activate G proteins by exchanging GDP for GTP on the alpha subunit. This leads to the alpha subunit dissociating from the beta-gamma dimer and interacting with effector proteins like enzymes or ion channels. The signaling then leads to second messengers like cAMP, IP3, or DAG.

Wrong options might include things like being ionotropic receptors (which they are not; that's ligand-gated ion channels), or having intrinsic tyrosine kinase activity (which is a feature of receptor tyrosine kinases). Another wrong option could be that they are all found in the nucleus, but GPCRs are cell surface receptors.

Clinical pearls: GPCRs are the target of about 30-40% of all drugs. Remember that they have seven transmembrane domains. Also, they are involved in various pathways, so their malfunction can lead to diseases like hypertension or diabetes.

Putting it all together, the correct answer would emphasize the G protein activation mechanism. The explanation should clarify why other options are incorrect, such as differentiating them from other receptor types. The clinical pearl about drug targets is high-yield for exams.

**Core Concept**
G protein-coupled receptors (GPCRs) are seven-transmembrane domain proteins that activate intracellular signaling via G proteins. Ligand binding induces a conformational change, allowing GPCR to interact with G proteins (Gα, Gβγ subunits), initiating downstream pathways like cAMP, IP3/DAG, or calcium mobilization.

**Why the Correct Answer is Right**
The correct answer identifies that GPCRs activate G proteins by promoting GDP-GTP exchange on the α-subunit. This activates the Gα subunit and Gβγ dimer, which then modulate effectors such as adenylyl cyclase, phospholipase C, or ion channels. This mechanism underlies most hormonal and neurotransmitter signaling, including β-adrenergic, muscarinic, and opioid receptors.

**Why Each Wrong Option is Incorrect**
**Option A:** Claims GPCRs are ligand-gated ion channels. Incorrect—ligand-gated ion channels (e.g., nicotinic acetylcholine receptor) directly open ion pores without G protein intermediates.
**Option B:** Suggests GPCRs use tyrosine kinase pathways. Incorrect—tyrosine kinase receptors (e.g., insulin receptor) phosphorylate tyrosine residues, a distinct mechanism from GPCR signaling.
**Option C:** States GPCRs are exclusively intracellular. Incorrect—GPCRs are cell surface receptors, unlike intracellular receptors (e.g., steroid hormone receptors).

**Clinical Pearl / High-Yield Fact**
GPCRs are the

✓ Correct Answer: C. M2